PCN1 ECONOMIC IMPACT OF ADOPTING PEMETREXED PLUS CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA INTO SCOTTISH CLINICAL PRACTICE
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67239-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)67239-7/fulltext
Title :
PCN1 ECONOMIC IMPACT OF ADOPTING PEMETREXED PLUS CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA INTO SCOTTISH CLINICAL PRACTICE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67239-7&doi=10.1016/S1098-3015(10)67239-7
First page :
Section Title :
Open access? :
No
Section Order :
466